ZA200007776B - Enzyme-protein complex. - Google Patents

Enzyme-protein complex.

Info

Publication number
ZA200007776B
ZA200007776B ZA200007776A ZA200007776A ZA200007776B ZA 200007776 B ZA200007776 B ZA 200007776B ZA 200007776 A ZA200007776 A ZA 200007776A ZA 200007776 A ZA200007776 A ZA 200007776A ZA 200007776 B ZA200007776 B ZA 200007776B
Authority
ZA
South Africa
Prior art keywords
enzyme
protein complex
protein
molecules
substance
Prior art date
Application number
ZA200007776A
Other languages
English (en)
Inventor
Hirokazu Ohbayashi
Yuriko Kitano
Original Assignee
Nichirei Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=18484551&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200007776(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nichirei Kk filed Critical Nichirei Kk
Publication of ZA200007776B publication Critical patent/ZA200007776B/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/535—Production of labelled immunochemicals with enzyme label or co-enzymes, co-factors, enzyme inhibitors or enzyme substrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2474/00—Immunochemical assays or immunoassays characterised by detection mode or means of detection
    • G01N2474/20—Immunohistochemistry assay
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/964—Chemistry: molecular biology and microbiology including enzyme-ligand conjugate production, e.g. reducing rate of nonproductive linkage

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
ZA200007776A 1999-12-22 2000-12-21 Enzyme-protein complex. ZA200007776B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP36555499A JP3781934B2 (ja) 1999-12-22 1999-12-22 酵素−タンパク質複合体

Publications (1)

Publication Number Publication Date
ZA200007776B true ZA200007776B (en) 2001-07-16

Family

ID=18484551

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200007776A ZA200007776B (en) 1999-12-22 2000-12-21 Enzyme-protein complex.

Country Status (16)

Country Link
US (2) US6613564B2 (fr)
EP (1) EP1111385B2 (fr)
JP (1) JP3781934B2 (fr)
KR (2) KR100649378B1 (fr)
CN (1) CN100338465C (fr)
AT (1) ATE468533T1 (fr)
AU (1) AU778084B2 (fr)
CA (1) CA2328805C (fr)
DE (1) DE60044420D1 (fr)
DK (1) DK1111385T4 (fr)
ES (1) ES2342146T5 (fr)
IL (1) IL140413A0 (fr)
NO (1) NO20006481L (fr)
NZ (1) NZ508945A (fr)
TW (1) TWI222516B (fr)
ZA (1) ZA200007776B (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050176068A1 (en) * 2002-04-26 2005-08-11 Emmert-Buck Michael R. Direct cell target analysis
US7476515B2 (en) 2003-01-17 2009-01-13 Ttc Co., Ltd. Affinity trap reactor and single-step process for purifying angiostatin-like fragment from human plasma using the same
AU2003256803B2 (en) * 2003-01-24 2009-09-17 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Target activated microtransfer
US7695752B2 (en) * 2003-01-24 2010-04-13 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Target activated microtransfer
ATE482396T1 (de) 2004-12-28 2010-10-15 Advanced Life Science Inst Inc Blockierter enzymsondenkomplex
US20060246523A1 (en) * 2005-04-28 2006-11-02 Christopher Bieniarz Antibody conjugates
EP1893241A2 (fr) * 2005-04-28 2008-03-05 Ventana Medical Systems, Inc. Nanoparticules flourescentes conjuguées á des anticorps via un linker peg
US7957466B2 (en) * 2005-09-16 2011-06-07 Sony Corporation Adaptive area of influence filter for moving object boundaries
US20070117153A1 (en) 2005-11-23 2007-05-24 Christopher Bieniarz Molecular conjugate
CA2796366C (fr) 2010-04-14 2017-12-05 Eiken Kagaku Kabushiki Kaisha Complexe de sondes etiquetees et de porteur hydrosoluble
EP3015474A4 (fr) 2013-06-28 2017-01-11 Kyushu University, National University Corporation COMPLEXE PROTÉINE-POLYMÈRE, POLYMÈRE CONTENANT UN SUBSTRAT DE TGase, MONOMÈRE CONTENANT UN SUBSTRAT DE TGase, PROCÉDÉ DE PRODUCTION DE COMPLEXE PROTÉINE-POLYMÈRE, ET PROCÉDÉ D'AMÉLIORATION DE FONCTIONNALITÉ DE PROTÉINE À L'INTERFACE OU À PROXIMITÉ DE L'INTERFACE D'UN SOLIDE ET D'UN LIQUIDE
KR102190207B1 (ko) * 2014-04-23 2020-12-15 가부시키가이샤 니찌레이 바이오사이언스 표적 마커 검출용 조합물
US11474101B2 (en) 2014-05-08 2022-10-18 Novodiax, Inc. Direct immunohistochemistry assay
CN106405087A (zh) * 2016-08-31 2017-02-15 上海科华生物工程股份有限公司 羊抗HBsAg多克隆抗体‑碱性磷酸酶交联物及其制备方法和检测试剂盒
US11988666B2 (en) 2019-09-02 2024-05-21 Fujirebio Inc. Lectin-binding substance measurement method, lectin-binding substance measurement kit, and blocked labeled lectin for use in these
JP7361543B2 (ja) * 2019-09-02 2023-10-16 富士レビオ株式会社 Ａｆｐ－ｌ３測定方法及びａｆｐ－ｌ３測定キット、並びに、これらに用いるブロック化標識レクチン
WO2021132470A1 (fr) * 2019-12-25 2021-07-01 富士レビオ株式会社 Bande immunochromatographique, dispositif immunochromatographique, kit immunochromatographique et procédé de détection de substance de test
CN113358863A (zh) * 2021-06-10 2021-09-07 武汉原谷生物科技有限责任公司 一种多聚酶标记的制作方法
CN114397440A (zh) * 2022-01-20 2022-04-26 百盛(广州)生物制品有限公司 一种基于多聚赖氨酸大分子（dgl）结构的酶标二抗制备及其方法
WO2025037528A1 (fr) * 2023-08-15 2025-02-20 ソニーグループ株式会社 Composé, conjugué, système de détection d'émission de lumière et dispositif de mesure

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0122028A1 (fr) * 1983-03-07 1984-10-17 E-Y Laboratories, Inc. Essai colorimétrique d'enzymes, un appareil diagnostique pour celui-ci et une méthode pour la fabrication de cet appareil
DK188184A (da) * 1983-04-20 1984-10-21 Enzo Biochem Inc Fremgangsmaade til dannelse af et kompleks af biologisk aktive eller funktionelle forbindelser og anvendelse af forbindelserne
AU3844485A (en) * 1984-02-09 1985-08-15 Enzo Biochem Inc. Heterologous detection of cabeled dna
EP0155224A3 (fr) * 1984-03-15 1987-05-06 CHROMAGENICS, Inc. Complexe en phase solide porteur d'une fonction sensible à un chromogène pour la détection d'un anticorp, d'un antigène, d'un récepteur ou d'un ligand
US4699784A (en) 1986-02-25 1987-10-13 Center For Molecular Medicine & Immunology Tumoricidal methotrexate-antibody conjugate
US5057313A (en) 1986-02-25 1991-10-15 The Center For Molecular Medicine And Immunology Diagnostic and therapeutic antibody conjugates
US5084560A (en) 1986-06-30 1992-01-28 Oncogen Immunoconjugates and methods for their use in tumor therapy
US4959306A (en) * 1986-11-28 1990-09-25 Sclavo, Inc. Labeling design for a binding assay reagent
GB8628488D0 (en) * 1986-11-28 1987-01-07 Baise Roile Ltd Edible product
NO173355C (no) * 1987-03-03 1993-12-01 Chugai Pharmaceutical Co Ltd Fremgangsm}te og selektiv bestemmelse av en h!ymolekylvekts hyaluronsyre og reagenssett for utf!relse av fremgangsm}ten
US5028524A (en) * 1987-04-24 1991-07-02 Takeda Chemical Industries, Ltd. Assay for anti-pre-S antibody
JPS6423300A (en) * 1987-07-17 1989-01-25 Ricoh Kk Spectrum generation system
US5053520A (en) 1988-09-22 1991-10-01 Abbott Laboratories Heterobifunctional maleimido containing coupling agents
JPH03158758A (ja) 1989-11-17 1991-07-08 Tosoh Corp デキストランを介して結合した二以上の物質の複合体及び該複合体の製造方法
ES2094920T3 (es) 1991-07-04 1997-02-01 Immunodex K S Reactivos y conjugados solubles en agua a base de polimeros que comprenden restos derivados de divinil sulfona.
JP3158758B2 (ja) 1993-02-19 2001-04-23 松下電器産業株式会社 端末アダプタ装置とデータ伝送方法
JPH10507997A (ja) 1993-06-11 1998-08-04 クールター コーポレイション Ｔ細胞の活性化および増殖を誘導するための抗ｃｄ３抗体−アミノデキストラン結合体
JP3825815B2 (ja) 1994-01-31 2006-09-27 信義 清水 上皮細胞増殖因子レセプターに対するモノクローナル抗体の結合体ならびにその複合体およびその細胞への嵌入方法
CA2184282A1 (fr) 1994-03-07 1995-09-14 Olavi Siiman Anticorps immobilises covalents sur des billes polymeriques
DE69638321D1 (de) * 1995-10-11 2011-03-03 Luminex Corp Gleichzeitige mehrfachanalyse klinischer proben
US5833924A (en) * 1995-12-22 1998-11-10 Universal Healthwatch, Inc. Sampling-assay device and interface system
JPH1084959A (ja) 1996-09-06 1998-04-07 Nobuyoshi Shimizu 細胞表面レセプターに対するモノクローナル抗体ならびにそのフラグメントの結合体ならびに複合体、それらの製法ならびに細胞への嵌入方法および使用方法
US5763158A (en) * 1997-02-06 1998-06-09 The United States Of America As Represented By The Secretary Of The Army Detection of multiple antigens or antibodies
JP3524401B2 (ja) * 1998-09-16 2004-05-10 株式会社ニチレイ 酵素抗体複合体およびその製造方法

Also Published As

Publication number Publication date
TWI222516B (en) 2004-10-21
ES2342146T3 (es) 2010-07-02
AU778084B2 (en) 2004-11-18
KR20010067472A (ko) 2001-07-12
ATE468533T1 (de) 2010-06-15
US20010005583A1 (en) 2001-06-28
CN1300942A (zh) 2001-06-27
EP1111385A3 (fr) 2002-09-04
HK1037728A1 (zh) 2002-02-15
IL140413A0 (en) 2002-02-10
US20040002146A1 (en) 2004-01-01
NO20006481D0 (no) 2000-12-19
EP1111385B2 (fr) 2014-02-26
KR100709052B1 (ko) 2007-04-18
DK1111385T3 (da) 2010-08-30
JP3781934B2 (ja) 2006-06-07
NO20006481L (no) 2001-06-25
JP2001181299A (ja) 2001-07-03
US6613564B2 (en) 2003-09-02
DK1111385T4 (da) 2014-06-02
DE60044420D1 (de) 2010-07-01
NZ508945A (en) 2002-07-26
CN100338465C (zh) 2007-09-19
CA2328805A1 (fr) 2001-06-22
KR100649378B1 (ko) 2006-11-24
CA2328805C (fr) 2009-08-18
AU7218400A (en) 2001-06-28
KR20060088864A (ko) 2006-08-07
ES2342146T5 (es) 2014-05-27
US7235369B2 (en) 2007-06-26
EP1111385B1 (fr) 2010-05-19
EP1111385A2 (fr) 2001-06-27

Similar Documents

Publication Publication Date Title
ZA200007776B (en) Enzyme-protein complex.
ES2171705T3 (es) Complejos de polipeptido-dendrimero.
DK261386A (da) Monoklonale antistoffer
WO2002042427A3 (fr) Marqueurs de masse pour analyse quantitative
ATE353864T1 (de) Fluorierung von proteinen und peptiden für positronemissionstomographie
EP0915336A3 (fr) Dispositif d'analyse chromatographique a elements opposables pour detection des analytes
EP0992794A3 (fr) Complèxe d'enzyme-anticorps et une méthode de préparation
EP0375422A3 (fr) Composé et procédés pour la détermination de la présence des amphétamines dans un échantillon suspect de contenir de l'amphétamine et/ou de la méthamphétamine
DE69530315D1 (de) Rückgewinnung und verwendungen von spezifischen bindungsreagenzen
AU2002349344A1 (en) Microfluidic extraction method
ES2148144T3 (es) Procedimiento para la estabilizacion de conjugados de enzima.
WO2003106649A3 (fr) Test d'un conjugue et ses utilisations
WO2002048403A3 (fr) Bioanalyse d'expression et d'activite de proteines multiples
AU2001296830A1 (en) Ligand based solution assay for low concentration analytes
WO2003016904A3 (fr) Etiquettes de sequence peptidique et leur procede d'utilisation
GB8927230D0 (en) Reagents
DE3851221D1 (de) Nichttrennender festphasen-enzymtest.
DE69025023D1 (de) Peptide und deren Benutzung
AU2001292118A1 (en) Dye-labelled peptide and its diagnostic use
WO2001000799A8 (fr) Nouvelle proteine et son adn
ES2173879T3 (es) Procedimiento para la preparacion de conjugados a base de un participe especifico en la fijacion y de una proteina que contiene hidratos de carbono
ATE200678T1 (de) Urogenitalkarzinom tlp peptidkomplex und abgeleitete antikörper
EP1702984A3 (fr) Méthode pour la détection du cancer de la prostate
AU3733199A (en) Antibodies and utilization thereof
AU682278B2 (en) Oligomer carrier molecules in which marker groups and haptens are selectively incorporated